scholarly journals P2-89 Quality of life is associated with accumulated risk factors for cardiovascular disease: a population-based study

2011 ◽  
Vol 65 (Suppl 1) ◽  
pp. A244-A244
Author(s):  
S. C. Fuchs ◽  
L. B. Moreira ◽  
D. J. Trevisol ◽  
M. Gus ◽  
M. Wiehe ◽  
...  
2021 ◽  
Vol 8 ◽  
pp. 100177
Author(s):  
Stephanie Popping ◽  
Meaghan Kall ◽  
Brooke E. Nichols ◽  
Evelien Stempher ◽  
Lisbeth Versteegh ◽  
...  

2007 ◽  
Vol 16 (9) ◽  
pp. 1539-1546 ◽  
Author(s):  
Mark S. Kaplan ◽  
Jean-Marie Berthelot ◽  
David Feeny ◽  
Bentson H. McFarland ◽  
Saeeda Khan ◽  
...  

2017 ◽  
Vol 28 (4) ◽  
pp. 603-610 ◽  
Author(s):  
Doroteia A Höfelmann ◽  
David A Gonzalez-Chica ◽  
Karen Glazer Peres ◽  
Antonio Fernando Boing ◽  
Marco Aurelio Peres

2015 ◽  
Vol 19 (3) ◽  
pp. 308-313 ◽  
Author(s):  
Colin Reilly ◽  
Patricia Atkinson ◽  
Krishna B. Das ◽  
Richard F.M. Chin ◽  
Sarah E. Aylett ◽  
...  

Author(s):  
Tatiana L. Karonova ◽  
Karina A. Pogosian ◽  
Liubov G. Yanevskaya ◽  
Olga D. Belyaeva ◽  
Elena N. Grineva

The review provides systematic information on the relation between pathology of parathyroid glands and cardiovascular disease (CVD). Recent studies have shown that actions of parathyroid hormone (PTH) and calcium affect the heart and vasculature through downstream actions of their receptors in the myocardium and endothelial cells, which lead to higher incidence of CVD among patients with parathyroid gland disorders (PGD). The mechanisms underlying this association also include insulin resistance and altered renin-angiotensinaldosterone axis among patients with primary hyperparathyroidism. However, low calcium and PTH level in hypoparathyroid patients are characterized by higher values of arterial stiffness, electrocardiogram abnormalities, vascular atherosclerosis and remodeling. These factors contribute to low quality of life among those patients. Knowledge of cardiovascular disease pathogenesis in patients with hyper- or hypoparathyroidism could help to improve quality of diagnostic and treatment and decrease the burden of cardiac risk factors. This review will be of interest to endocrinologists and cardiologists, and other specialists.


Sign in / Sign up

Export Citation Format

Share Document